Morphological differences in epithelial papillae and microvascular architecture according to site in cat filiform papillae
Journal of Osaka Dental University · 01.04.2015 · 49 (1) · 35-48
DOI: 10.18905/jodu.49.1_35 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Osaka Dental University, erschienen am 01.04.2015. Verfasst von Masaya Hikida und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Regarding cat filiform papillae (FP), Kobayashi et al. (1988, 1992) 2 and Ojima et al. (1996, 2000) 4 reported on the epithelial papillae (EP) and microvascular architecture, respectively. Both noted that the morphology of the FP differed according to location. However, the morphologies of EP and the microvascular architecture have not been compared for the same site. We used a scanning electron microscope (SEM) to observe the EP and microvascular architecture of the FP in each site of the dorsum of the feline tongue, and compared the morphologies of the EP and the microvascular architecture in each site. We were able to obtain novel findings regarding EP and the microvascular architecture.
Schlagwörter
Zitieren
APA
Hikida, M., Takemura, A., & Suwa, F. (2015). Morphological differences in epithelial papillae and microvascular architecture according to site in cat filiform papillae. Journal of Osaka Dental University, 49(1), 35-48. https://doi.org/10.18905/jodu.49.1_35
Vancouver
Hikida M, Takemura A, Suwa F. Morphological differences in epithelial papillae and microvascular architecture according to site in cat filiform papillae. Journal of Osaka Dental University. 2015;49(1):35-48. doi:10.18905/jodu.49.1_35
BibTeX
@article{Hikida2015,
author = {Hikida, Masaya and Takemura, Akimichi and Suwa, Fumihiko},
title = {Morphological differences in epithelial papillae and microvascular architecture according to site in cat filiform papillae},
journal = {Journal of Osaka Dental University},
year = {2015},
volume = {49},
number = {1},
pages = {35--48},
doi = {10.18905/jodu.49.1_35}
}
EUVIMED